Virtual Housecalls: Redesigning Pediatric Primary Care Adolescent Obesity Treatment
VHC
2 other identifiers
interventional
500
1 country
1
Brief Summary
This pragmatic randomized clinical trial tests a novel intensive health behavior and lifestyle intervention, conducted via telehealth, to treat class I adolescent obesity in pediatric primary care. Results will inform scalable approaches that meet the recommended treatment dose and effectively treat obesity in this setting.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Aug 2026
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 17, 2025
CompletedFirst Posted
Study publicly available on registry
November 24, 2025
CompletedStudy Start
First participant enrolled
August 1, 2026
ExpectedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2030
Study Completion
Last participant's last visit for all outcomes
January 1, 2030
December 17, 2025
December 1, 2025
3.4 years
November 17, 2025
December 11, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Body Mass Index (BMI) Change
Adolescent height (cm) and weight (kg) will be measured in triplicate by trained staff wo are masked to treatment assignment. Height and weight values will be used to calculate Body Mass Index (BMI) specific to age and sex using the Centers for Disease and Control reference data.
0 - 6 months
Secondary Outcomes (5)
Body Mass Index (BMI) Maintenance
6 - 12 months
Energy Intake
0-6-months, 6-12-months
Diet Quality
0-6-months, 6-12-months
Physical Activity
0-6-months, 6-12-months
Treatment Dose
0-6-months
Study Arms (2)
Virtual Housecalls Intervention (VHC)
EXPERIMENTALIncludes standard in-person pediatric primary care, 6 months of telehealth sessions with a behavior coach (3 months with weekly sessions, 3 months with bi-weekly sessions), and weekly exercise videos sent electronically for the 6 month intervention. Sessions include real-time skill building that uses items or space in families' home to tailor the treatment and personalize content application to their context.
Enhanced Treatment as Usual (TAU+)
NO INTERVENTIONIncludes standard in-person pediatric primary care, enhanced with PPCP training on obesity treatment guidelines and publicly available education regarding healthy eating and exercise, delivered to participants on a contact schedule matched to the intervention group.
Interventions
26 contact hours of evidence-based intensive health and behavioral lifestyle treatment, as per the American Academy of Pediatrics Clinical Practice Guidelines
Eligibility Criteria
You may qualify if:
- English or Spanish-speaking
- years of age
- Receiving care at a participating clinic
- Body Mass Index (BMI) ≥95% and \<120% of the 95%
- Access to a mobile device with a webcam that can receive texts
- English or Spanish-speaking
- Primary legal guardian ≥18 years of age living with the adolescent
You may not qualify if:
- conflicts that would inhibit the ability to participate in all aspects of the study as outlined in the study protocol
- family plans to move outside of the study area or plans to no longer be a patient at a participating clinic in the 12 month study period
- the primary care provider or PI determines that the study is not clinically or medically appropriate (e.g., significant psychiatric, cognitive, physical or developmental conditions that would impair their ability to complete assessments, participate in study sessions, or conduct physical activity) based on screening at study onset
- adolescent exhibits severe dietary restriction or compensatory behavior (e.g., vomiting, laxative abuse) based on screening at study onset and clinical interview by a study psychologist
- adolescent is currently pregnant/plans to become pregnant during study period
- adolescent is participating in another weight loss program, has had or plans to undergo weight loss surgery
- adolescent has a chronic medical condition(s) and/or uses medication that substantially impacts or interferes with growth, appetite, weight or physical activity participation
- adolescents taking anti-obesity medication are ineligible if they are not a stable dose for at least 3 months prior to study participation
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Children's Hospital of Richmond at VCU Healthy Lifestyles Center
Henrico, Virginia, 23239, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Melanie K Bean, PhD
Virginia Commonwealth University
- PRINCIPAL INVESTIGATOR
Shari Barkin, PhD
Emory University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- INVESTIGATOR, OUTCOMES ASSESSOR
- Masking Details
- Assessors and MPIs will be masked to treatment group
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 17, 2025
First Posted
November 24, 2025
Study Start (Estimated)
August 1, 2026
Primary Completion (Estimated)
January 1, 2030
Study Completion (Estimated)
January 1, 2030
Last Updated
December 17, 2025
Record last verified: 2025-12
Data Sharing
- IPD Sharing
- Will not share